Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 07 Oct 2026 for TriSalus Life Sciences, Inc., €1,156. Read the official filing
Filing timeline
BuySaleBryan F. Cox
Insider track record
Disclosed buys
0
Disclosed sells
3
Signal history
Bryan F. Cox: trading record in brief
All filings by Bryan F. Cox on record concern TriSalus Life Sciences, Inc. Over a trading history stretching from 12 February 2024 to 5 October 2026, the count stands at 8 filings.
The open-market record consists of 3 sales worth €6,467, with no purchase. Besides market trades, the filings include 5 share grants. In 2026 alone, the filings show no purchases and 2 sales.
On 7 October 2026 came the latest disclosure, an open-market sale for €1,156 in TriSalus Life Sciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Bryan F. Cox
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
296 shares@ US$4.39Common StockSEC:0001628280-26-065326:0
1,138 shares@ US$4.135.2% of flowCommon StockSEC:0001628280-26-020189:0
40,000 shares0Common StockSEC:0001981787-25-000004:0
15,722 shares@ US$5.1893.2% of flowCommon StockSEC:0001826667-25-000061:0
11,450 shares0Common StockSEC:0001415889-25-004685:0
10,625 shares0Common StockSEC:0001415889-25-002289:0
314 shares@ US$4.441.6% of flowCommon StockSEC:0001415889-24-029909:0
14,752 shares0Common StockSEC:0001415889-24-003815:0
8 of 8 declarations
